Localized cancers usually have a higher survival rate than cancers that have spread. Treatment options range from external radiation therapy to palliative treatments, which help to relieve symptoms and improve quality of life. Fortunately, there are no known fatalities associated with endometrial cancer. In rare cases, however, the disease can spread.
Primary surgery and adjuvant chemotherapy can both improve survival rates. Preoperative radiotherapy has been shown to shrink tumors in patients who have early-stage endometriosis cancer. Patients who have had chemotherapy or radiotherapy in combination with surgery are significantly more likely to survive. Postoperative radiotherapy also improves outcomes. But it is important to note that surgical treatments are not without side effects. Many women choose chemotherapy for endometrial cancer as their main treatment option.
The etiology of endometrial cancer is not completely understood. However, certain factors are suspected to increase your risk. For example, insulin resistance and hyperandrogenemia are known risk factors. Although these factors are not entirely clear, they are thought to contribute to a higher risk of developing endometrial cancer. But no one knows for sure if these factors are the cause of endometrial cancer. It is important to note that endometriosis cancer is caused by changes in a woman’s hormones.
Pregnant women are at increased risk of developing endometrial cancer because estrogen thickens the endometrium during pregnancy. However, after menopause, estrogen-only hormones are known to increase risk. Women who take estrogen-only hormone replacement therapy, such as tamoxifen, also increase their risk. This type of treatment is not recommended for women who have not undergone hysterectomy.
While the prognosis for type 1 endometrial cancer is generally good, women who develop type 2 endometrial cancers have a more dismal outlook. The high-grade endometrioid carcinomas have a poor prognosis and often metastasize through the lymphatic system. They also spread to the abdomen and pelvis. As a result, the prognosis for both types of endometriosis cancer is largely uncertain.
The American Cancer Society reports that most endometrial cancers are adenocarcinomas. These cancers develop in glandular tissues, including the endometrium. They are typically slow-growing but easier to treat if detected early. However, early diagnosis is important because it improves the patient’s chances of survival. There are various symptoms of endometriosis cancer, but they are not usually serious.
Most endometrial cancers are invasive and begin as preinvasive intraepithelial lesions. They spread to other areas of the body, including the fallopian tubes, ovaries, and the lymph nodes. In rare cases, adnexal dissemination is the result of the disease spreading. Although no specific treatment is currently available for endometrial cancer, it is recommended for those with suspected symptoms.
The symptoms of endometrial cancer vary depending on its stage. Early detection can help determine the best treatment options. A multidisciplinary team of specialists should evaluate the patient for signs and symptoms. Patients must be evaluated for their age, reproductive status, habitus, health, and understanding of the disease. Psychological factors, as well as socio-economic status, must be evaluated as well. In addition, intraperitoneal metastases must be ruled out as well.
